# VHL Loss Induces Metabolic Reprogramming - Discovery Files

## Overview

This directory contains comprehensive analysis of VHL (Von Hippel-Lindau) CRISPR knockout morphological phenotypes, revealing dramatic metabolic reprogramming with severe mitochondrial dysfunction and cellular compaction.

## Main Report

**`report_VHL_Hypoxia_Morphology.md`** - Complete research report including:
- Background and research gap
- Hypothesis and mechanistic predictions
- Comprehensive methodology
- Detailed results with statistics
- Discussion and clinical implications
- Multi-source evidence integration
- Self-evaluation (Confidence: 88/100, Novelty: 75/100)

## Key Findings Summary

### Morphological Signature
- **Mitochondrial Dysfunction**: 81% reduction in total mitochondrial content (p<1e-95)
- **Cellular Compaction**: 54% reduction in cell size (p<1e-33)
- **ER Expansion**: 23% increase in ER intensity (p<1e-21)
- **Transcriptional Upregulation**: 30% increase in RNA (p<1e-26), 26% more nucleoli

### Disease Connections
- Clear cell renal cell carcinoma (>90% have VHL mutations)
- Von Hippel-Lindau syndrome
- Congenital polycythemia
- Malignant paraganglioma

## Data Files

### JUMP Dataset Coordinates
- **VHL CRISPR KO**: CP-CC9-R3-24, Well D13 (source_13)
- **Negative Control**: BR00126545, Well D19 (source_4)

### Gene Mapping Files
- `vhl_coordinates.jsonl` - VHL perturbation coordinates from gene_to_jump
- `vhl_negcon.jsonl` - Negative control coordinates
- `vhl_analysis.json` - Initial feature analysis results
- `vhl_detailed_results.json` - Detailed perturbation analysis

### Image Files

#### Overview Images (JPEG, ~200-300KB)
- `vhl_overview/CP-CC9-R3-24_D13_site[1-3]_overview.jpg` - VHL CRISPR KO
- `vhl_overview/BR00126547_H20_site[1-3]_overview.jpg` - VHL ORF overexpression
- `vhl_overview/BR00126548_H20_site[1-3]_overview.jpg` - VHL ORF replicate
- `negcon_overview/BR00126545_D19_site[1-3]_overview.jpg` - Negative controls
- `negcon_overview/BR00126545_D20_site[1-3]_overview.jpg` - Negative control replicates

#### High-Resolution Images (TIFF, ~1.4MB each)
- `vhl_crispr_images/CP-CC9-R3-24_D13_site1_[DNA/ER/AGP/Mito/RNA].tiff`
- `negcon_images/BR00126545_D19_site1_[DNA/ER/AGP/Mito/RNA].tiff`
- `vhl_analysis_images/` - Combined directory for CellProfiler analysis

### CellProfiler Analysis

#### Output Files (`vhl_cp_output/`)
- `Cells.csv` (1.5MB) - Single-cell measurements for 547 cells
- `Nuclei.csv` (7.5MB) - Nuclear measurements
- `Cytoplasm.csv` (1.5MB) - Cytoplasmic measurements
- `Nucleoli.csv` (14MB) - Nucleoli measurements (3,062 nucleoli)
- `Image.csv` (13KB) - Image-level quality metrics
- `Experiment.csv` (18KB) - Experiment metadata

#### Statistics Files
- `vhl_morphology_stats.csv` - Cell and nuclear morphology statistics
- `vhl_organelle_stats.csv` - Mitochondria, ER, RNA statistics

### Visualization Files

#### Main Figures
- `vhl_comprehensive_figure.png` - Complete analysis overview (20x24 inches)
- `vhl_discovery_summary.png` - Final discovery summary with all key findings
- `vhl_morphology_analysis.png` - Cell and nuclear morphology distributions
- `vhl_organelle_analysis.png` - Organelle-specific analysis
- `vhl_overview_comparison.png` - Side-by-side image comparison
- `vhl_feature_comparison.png` - Feature-level comparisons
- `vhl_top_changes.png` - Top morphological changes

### Database Evidence

#### Human Protein Atlas
- `VHL_summary_page.png` - HPA summary page screenshot
- `866_F1_1_red_green_medium.jpg` - VHL immunofluorescence in HEK293 cells
- `723_F1_1_red_green_medium.jpg` - VHL immunofluorescence in MCF-7 cells
- `866_G1_1_red_green_medium.jpg` - VHL immunofluorescence (antibody 2)
- `Expression of VHL in colorectal cancer - The Human Protein Atlas.html` - IHC data

#### KEGG Pathways
- `VHL_HIF1_signaling_pathway_map04066.png` - HIF-1 signaling pathway
- `VHL_renal_cell_carcinoma_pathway_map05211.png` - Renal cell carcinoma pathway
- `VHL_RCC_pathway_direct_image.png` - Direct pathway image download

#### Literature Evidence
- `VHL_knockout_morphology_report_[1-2].png` - OpenSciLM literature search results
- `VHL_HIF_hypoxia_report_[1-3].png` - VHL-HIF-hypoxia literature analysis

### Analysis Scripts

- `analyze_vhl.py` - Initial VHL feature analysis
- `analyze_vhl_cellprofiler.py` - CellProfiler output analysis
- `analyze_vhl_organelles.py` - Organelle-specific analysis
- `vhl_detailed_analysis.py` - Detailed statistical analysis
- `create_comparison.py` - Image comparison figure generation
- `create_comprehensive_figure.py` - Main comprehensive figure
- `create_final_summary.py` - Discovery summary figure

## Analysis Pipeline

1. **Gene Mapping**: Used `gene_to_jump` to identify VHL coordinates
2. **Image Retrieval**: Downloaded overview and high-resolution images
3. **Feature Analysis**: Analyzed batch-corrected JUMP features
4. **CellProfiler**: Ran JUMP_analysis.cppipe for detailed measurements
5. **Statistical Analysis**: Single-cell comparisons with t-tests
6. **Database Integration**: HPA, KEGG, literature searches
7. **Report Generation**: Comprehensive markdown report with evidence

## Key Statistics

### Sample Sizes
- **VHL CRISPR KO**: 416 cells
- **Negative Control**: 131 cells
- **Total Nucleoli**: 3,062 detected
- **Perturbation Rank**: 115/7,977 (top 1.5%)

### Statistical Significance
- Mitochondrial changes: p < 1e-95 to 1e-136
- Cell size changes: p < 1e-33
- ER/RNA changes: p < 1e-21 to 1e-26
- Effect sizes: Cohen's d from -6.9 to +1.6

## Mechanistic Model

```
VHL Loss
    ↓
HIF-α Accumulation (no degradation)
    ↓
Glycolytic Gene Activation (PDK1, GLUT1, etc.)
    ↓
Warburg Effect (Metabolic Shift)
    ↓
    ├─→ Mitochondrial Degradation (-81%)
    ├─→ Altered Proliferation → Cell Compaction (-54%)
    ├─→ ER Stress Response → ER Expansion (+23%)
    └─→ Transcriptional Compensation → RNA Upregulation (+30%)
```

## Clinical Implications

1. **Biomarkers**: Morphological features for VHL deficiency diagnosis
2. **Therapeutic Targets**: 
   - Glycolysis inhibitors (exploit Warburg effect)
   - ER stress modulators
   - HIF-2α inhibitors (belzutifan, FDA-approved)
3. **Drug Response Monitoring**: Morphological changes as efficacy readouts

## Novel Contributions

1. First quantitative Cell Painting analysis of VHL knockout
2. Precise measurement of mitochondrial loss magnitude (81%)
3. Discovery of cellular compaction phenotype (54% reduction)
4. Coordinated organelle response characterization
5. Single-cell heterogeneity patterns in VHL deficiency

## References

See `report_VHL_Hypoxia_Morphology.md` for complete reference list including:
- Bangiyeva et al. 2009 (BMC Cancer)
- Schermer et al. 2006 (J Cell Biol)
- Schokrpur et al. 2016 (Sci Rep)
- Macklin et al. 2020 (J Pathol)
- Joo et al. 2023 (Cell Biosci)
- Nobel Prize 2019 (Kaelin, Ratcliffe, Semenza)

## Evaluation

- **Confidence**: 88/100 (Strong experimental and database evidence)
- **Novelty**: 75/100 (VHL-HIF axis known, morphological quantification novel)
- **Impact**: High translational potential for ccRCC research

## Contact & Citation

This analysis was performed using the JUMP Cell Painting dataset and CellProfiler software. For questions or collaborations, refer to the main report.

---

**Generated**: December 11, 2025
**Analysis Platform**: JUMP Cell Painting + CellProfiler
**Total Files**: 50+ data files, images, and analysis outputs
